The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction

被引:10
|
作者
van der Leest, Paul [1 ]
Schuuring, Ed [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol EA10, Lab Mol Pathol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
关键词
TUMOR DNA;
D O I
10.1002/1878-0261.12646
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [31] Circulating cell-free DNA: a potential biomarker in lung cancer
    Taylor, Fiona
    Teare, M. Dawn
    Cox, Angela
    Woll, Penella J.
    LUNG CANCER MANAGEMENT, 2013, 2 (05) : 407 - 422
  • [32] POTENTIAL AS BIOMARKERS OF CIRCULATING CELL-FREE DNA IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Iwanaga, Terunao
    Sakuma, Takahumi
    Fujita, Naoto
    Koroki, Keisuke
    Kobayashi, Kazuhumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Tawada, Akinobu
    Kato, Naoya
    HEPATOLOGY, 2020, 72 : 683A - 683A
  • [33] Circulating cell-free DNA for response evaluation of intravascular lymphoma
    Deeren, Dries
    Van der Linden, Malaika
    Dedeurwaerdere, Franceska
    Deleu, Lien
    Meert, Caressa
    Menten, Bjorn
    Van Dorpe, Jo
    ANNALS OF HEMATOLOGY, 2019, 98 (08) : 2021 - 2023
  • [34] Circulating cell-free DNA for response evaluation of intravascular lymphoma
    Dries Deeren
    Malaïka Van Der Linden
    Franceska Dedeurwaerdere
    Lien Deleu
    Caressa Meert
    Björn Menten
    Jo Van Dorpe
    Annals of Hematology, 2019, 98 : 2021 - 2023
  • [35] Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer
    Wang, W.
    Liang, M.
    Ma, G.
    Li, L.
    Zhou, W.
    Xia, T.
    Xie, H.
    Wang, S.
    NEOPLASMA, 2017, 64 (04) : 611 - 618
  • [36] Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden
    Bhangu, Jagdeep Singh
    Taghizadeh, Hossein
    Braunschmid, Tamara
    Bachleitner-Hofmann, Thomas
    Mannhalter, Christine
    SURGICAL ONCOLOGY-OXFORD, 2017, 26 (04): : 395 - 401
  • [37] Circulating cell-free DNA in plasma of patients with Obstructive Sleep Apnea as a potential screening marker
    Lee, S. G.
    Lee, C. K.
    Cho, K. J.
    Kim, S. W.
    Kim, J. K.
    Shin, C.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A27 - A27
  • [38] Prediction and response evaluation of EGFR blockade for colorectal cancer by using circulating cell-free DNA
    Iwai, Takuma
    Yamada, Takeshi
    Kan, Hatato
    Koizumi, Michihiro
    Shinji, Seiichi
    Takahashi, Goro
    Watanabe, Atushi
    Matumoto, Satoshi
    Matuda, Akihisa
    Yamagishi, Aya
    Yokoyama, Yasuyuki
    Uchida, Eiji
    CANCER RESEARCH, 2015, 75
  • [39] Noninvasive prediction of response to cancer therapy using promoter profiling of circulating cell-free DNA
    Guo, Zhi-Wei
    Xiao, Wei-Wei
    Yang, Xue-Xi
    Yang, Xu
    Cai, Geng-Xi
    Wang, Xiao-Jing
    Han, Bo-Wei
    Li, Kun
    Zhai, Xiang-Ming
    Li, Fen-Xia
    Huang, Li-Min
    Wu, Ying-Song
    Gao, Yuan-Hong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (05):
  • [40] BRAF and KRAS mutation testing in cell-free DNA and circulating tumor cells from blood of patients with metastatic cancers.
    Janku, Filip
    Legendre, Ben
    Richardson, Katherine
    Falchook, Gerald S.
    Naing, Aung
    Holley, Veronica R.
    Hong, David S.
    Zinner, Ralph G.
    Fu, Siqing
    Tsimberidou, Apostolia M.
    Subbiah, Vivek
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Wheler, Jennifer J.
    Stepanek, Vanda M.
    Cabrilo, Goran
    Luthra, Rajyalakshmi
    Meric-Bernstam, Funda
    Kruempel, Amy
    Pope, Jaclyn
    Cubrich, Courtney
    Wu, Grant
    Shi, Yanggu
    Lewis, Marcia
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)